[[7, 35, [[3, 547, "Table 2. Functionalized Pyrazole SAR"]]], [238, 307, [[34, 160, "Compound"], [270, 302, "R2"], [421, 541, "IL-1 IC50 (M)a"], [611, 695, "cLogP cLogD"], [753, 820, "LLEb"]]], [335, 396, [[80, 116, "14"], [448, 516, "0.086"], [629, 677, "2.6 0.9"], [768, 808, "6.2"]]], [455, 516, [[80, 116, "15"], [454, 509, "2.57"], [632, 676, "2.4 0.5"], [767, 807, "5.1"]]], [597, 658, [[79, 116, "16"], [454, 507, "0.41"], [632, 676, "3.0 0.9"], [767, 810, "5.5"]]], [755, 820, [[80, 113, "17"], [402, 562, "0.063  0.042 (n=28)"], [632, 676, "2.0 0.4"], [767, 810, "6.7"]]], [914, 975, [[80, 114, "18"], [454, 509, "0.43"], [632, 676, "2.1 0.4"], [767, 810, "6.0"]]], [1075, 1132, [[80, 113, "19"], [460, 503, "6.2"], [636, 676, "1.8 0"], [768, 808, "5.2"]]], [1204, 1235, [[4, 848, "'Inhibition of the NLRP3 inflammasome pathway was assessed by"]]], [1243, 1272, [[3, 851, "quantifying IL-1 release from LPS + nigericin stimulated hPBMCs"]]], [1278, 1307, [[4, 851, "(n = 1 for all compounds except compound 17 which is reported as"]]], [1311, 1346, [[0, 853, "geometric mean  SD). LLE was calculated using the following"]]], [1348, 1381, [[3, 495, "equation: LLE = pICso IL-1 - cLogD."]]]]